Przezskórna angioplastyka Y-pomostu żylnego u pacjenta z niestabilną dławicą piersiową : czy zwężenie bifurkacji Y-pomostu żylnego jest nadal wyzwaniem? by Szolc, Piotr et al.
www.journals.viamedica.pl/folia_cardiologica
Folia Cardiologica 2019 
tom 14, nr 5, strony 504–508 
DOI: 10.5603/FC.2019.0102 




Address for correspondence: dr n. med. Bartłomiej Guzik, Klinika Kardiologii Interwencyjnej, Collegium Medicum, Uniwersytet Jagielloński, Krakowski 
Szpital Specjalistyczny im. Jana Pawła II, ul. Prądnicka 80, 31–202, Kraków, Poland, tel. +48 12 614 35 01, e-mail: b.guzik@uj.edu.pl
Percutaneous angioplasty of venous Y-bypass-graft  
in patient with unstable angina:  
Y-bypass graft bifurcation lesions remain a challenge
Przezskórna angioplastyka Y-pomostu żylnego u pacjenta z niestabilną dławicą 
piersiową. Czy zwężenie bifurkacji Y-pomostu żylnego jest nadal wyzwaniem?
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Abstract
A 71 year-old patient with a history of coronary artery bypass grafting was admitted to the Department of Interventional 
Cardiology, John Paul II Hospital, Krakow with acute coronary syndrome — unstable angina. Coronary angiography re-
vealed significant narrowing of a bifurcated venous bypass graft as the last remaining vessel. After consultation from 
the Heart Team, he underwent percutaneous coronary angioplasty of the venous bypass with implantation of a self-
apposing sirolimus-eluting stent (Stentys). The technical aspects of this procedure, such as the use of a left ventricle 
assist device, additional imaging (intravascular ultrasound), the type of approach and stent, and the protection of the 
vessel are discussed in this article. A patient with numerous co-morbidities and severely decreased function of the left 
ventricle was in fact a candidate for percutaneous revascularisation. Eight months later, the patient had a cardioverter- 
-defibrillator implanted in primary prevention of sudden cardiac death due to symptomatic chronic heart failure with re-
duced ejection fraction. This discussion raises the topic of the long-term effectiveness of angioplasty in this group of pa-
tients. Myocardial revascularisation in a patient with severe symptoms and a diseased last remaining vessel should be 
obligatory. However, multiple comorbidities increase the risk of cardiac surgery as well as of percutaneous angioplasty. 
The critical question here is: should the treatment be invasive or would the better option be optimal medical treatment?
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Case report
A 71 year-old patient was admitted to our department 
with unstable angina, recently advancing to class III of the 
Canadian Cardiovascular Society classification. Levels of 
myocardial necrosis markers were within the normal range 
[high-sensitivity troponin T (hsTnT) 0.011 ng/mL, creatine 
kinase myocardial bound [CK-MB] 11 U/L; Table 1). The 
patient had a previous history of arterial hypertension, 
dyslipidemia, chronic heart failure with reduced ejection 
fraction, persistent atrial fibrillation, Leriche syndrome and 
chronic kidney disease (stage III).
In 1995, the patient underwent coronary artery by-
pass grafting with Y-graft [saphenous vein grafts (SVG)] 
to diagonal and marginal branches as treatment of acute 
coronary syndrome. Since then, the patient had had two 
505www.journals.viamedica.pl/folia_cardiologica
Piotr Szolc et al., Angioplasty of venous-Y-bypass graft
non-ST-segment myocardial infarctions (NSTEMI). These 
were treated with coronary angioplasty of SVG to marginal 
branch in 2009 (bare metal stent), and of SVG to diagonal 
branch in 2012 (drug eluting stent).
The echocardiography performed on admission sho-
wed severely reduced left ventricular ejection fraction 
(LVEF = 26%), mild mitral regurgitation, and severe tricuspid 
regurgitation with features of severe pulmonary hypertension 
[RVSP (right ventricular systolic pressure) = 69 + 13 mm Hg]. 
Coronary angiography revealed severe stenosis in the Y-graft 
(SVG) prior to its bifurcation, with an optimal effect of the 
previous angioplasty procedures (Figures 1A, B).
The patient was consulted by the local Heart Team, 
who suggested percutaneous revascularisation. This pro-
cedure was performed through right brachial access using 
an Amplatz Right 2.0/7 F guide catheter. A FilterWire was 
delivered to the SvG-Dg graft branch supplying the larger 
area of the myocardium and a Whisper ES was delivered 
to protect the second branch of the Y-graft [SVG to obtuse 
marginal branch (OM)] as a side branch (Figure 1C). Pre-
dilatation with non-compliant (NC) balloons (3.5/15 mm 
and 4.0/15 mm) was performed (Figure 1D). A Stentys 
X-Position 3.5–4.5/22 mm stent was implanted in the 
Y-junction (bifurcation) over the FilterWire (Figure 1E). 
Proximal optimisation was carried out with the balloon, and 
rewiring of OM was carried out with the Whisper ES. A final 
kissing technique using an NC 5.0/15 mm balloon in SVG 
to Dg and an NC 3.0/15 mm balloon in SVG to OM was 
performed (Figure 1F). Finally, the FilterWire was removed, 
and we achieved the optimal result, with TIMI (Thrombolysis 
in Myocardial Infarction) III flow to both branches (Fig-
ure 1G, H). The patient received 440 mL of isotonic contrast 
(Visipaque 320). The radiation dose was 2,382 mGy. We 
observed slightly increased levels of myocardial necrosis 
markers (hsTnT 0.120 ng/mL, CK-MB 22 U/L) without other 
criteria for type IV acute coronary syndrome (ACS) (Fourth 
Universal Definition of Myocardial Infarction). The patient 
was discharged home after four days.
On discharge, the patient received: acetylsalicylic 
acid (ASA), clopidogrel, dabigatran at 110 mg, metoprolol 
succinate, ramipril, spironolactone, furosemide, atorvas-
tatin, and pantoprazole. ASA was discontinued after one 
month.
Follow-up
Follow up was performed seven months later. All symp-
toms had decreased [class I/II Canadian Cardiovascular 
Society (CCS)] with persistent symptoms of heart failure 
[class II New York Heart Association (NYHA)]. The patient 
reported intermittent claudication at class IIb Fontaine with 
a distance < 100 m.
Echocardiography showed severely reduced LVEF 
(22%), moderate mitral regurgitation, and severe tricuspid 
regurgitation with features of severe pulmonary hyperten-
sion (RVSP = 65 + 15 mm Hg). The result of N-terminal 
fragment pro-B-type natriuretic peptide (NT-proBNP) was 
elevated (2,925 pg/mL).
An implantable cardioverter-defibrillator (ICD) was 
successfully implanted in August 2017. At the most recent 
follow-up, the patient’s family informed us that the patient 
died in November 2017.
Discussion
The advantages of venous Y-graft over multiple venous 
grafts are: fewer anastomoses on the ascending aorta and 
better position of the graft around the heart. On the other 
hand, proximal narrowing or the occlusion of the Y-graft 
causes ischaemia of the larger area of the myocardium 
[1]. Coronary angioplasty of bifurcation lesions remains 
a complex and insufficiently studied subject, particularly in 
SVG. The treatment of recurrent significant atherosclerotic 
lesions in grafts has always been a challenging issue, and 
should be considered as such [2].
In cases of unusual anastomoses, it may be bene-
ficial to consider the Heart Team’s advice and be espe-
cially careful regarding equipment selection. As has been 
demon strated, appropriate referral to the Heart Team has 
beneficial long-term effects on clinical events after revas-
cularisation [3, 4]. Gradually progressing reduction of left 
Table 1. Laboratory results during follow-up
Parameter Admission Discharge 9 months
Haemoglobin [g/dL] 12.9 13.6 11.8
K+ [mmol/L] 4.2 4.2 4.1
Creatinine [μmol/L] 122 120 133
eGFR 51 52 46
Total cholesterol [mmol/L] 3.24 2.39
LDL [mmol/L] 2.13 1.46
HDL [mmol/L] 0.83 1.04
Triglycerides [mmol/L] 0.86 0.5
K — potassium; eGFR — estimated glomerular filtration rate; LDL — low-density lipoproteins; HDL — high-density lipoproteins
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Figure 1A, B. Coronary angiography presenting bifurcation lesion before percutaneous coronary intervention (PCI); C. Protection of venous 
graft’s branch to Dg; D. Pre-dilatation of bifurcation lesion; E. Implantation of self-apposing sirolimus-eluting stent (Stentys); F. Optimisation 
using the ‘kissing balloons’ technique; G, H. Coronary angiogram presenting the final result of bifurcation lesion angioplasty
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In our case, we used a self-apposing stent, although in 
the literature other techniques such as ‘DK crush stenting’ 
have been described [6, 7]. In a case of intervention in 
a patient afflicted with numerous co-morbidities and a low 
ejection fraction, the use of a left ventricle assist device 
(LVAD) should be considered. We could not use any LVAD, 
but because the haemodynamic status remained stable 
during the whole procedure, we decided not to use an 
intra-aortic balloon pump (IABP).
Additional imaging methods [e.g. intravascular ultraso-
und (IVUS)] could be considered to verify the effectiveness. 
However, in this case we decided not to perform it since 
a self-apposing system ensures optimal stent apposition. 
The patient obtained a high radiation dose as well as a high 
volume of contrast dye simultaneously during this procedure.
Ischaemic aetiology of cardiomyopathy is one of the 
most common reasons for chronic heart failure. Myocardial 
revascularisation in patients suffering from chronic heart 
failure should be obligatory when there are severe symp-
toms. However, due to the high risk of recurrent surgery, 
percutaneous intervention is the preferred option. Multiple 
comorbidities increase the risk of cardiac surgery as well 
as that of percutaneous procedures.
Therefore the decision whether to treat invasively, or to 
defer and treat with optimal medical therapy, is a question 
of critical importance.
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ventricle function is in fact the result of factors other than 
weak myocardial perfusion [5].
In this case, a significantly narrowed venous graft 
as the last remaining vessel in a patient with ACS was 
an indication for performing coronary angioplasty. As 
we mentioned before, the Heart Team suggested per-
cutaneous revascularisation as the preferred option 
for a patient with (last remaining vessel/such coronary 
status) and low ejection fraction. Referring such patients 
to centres with highly experienced staff is advisable 
in order to ensure patient safety. The efficiency of the 
percutaneous coronary intervention (PCI) technique is 
gradually evolving as new devices are introduced. We 
prefer a radial approach for coronary percutaneous 
procedures; however we did not use a sirolimus-eluting 
coronary stent-on-a-wire Integrated Delivery System 
(Slender IDS), nor a sheathless guide. Since this pa-
tient had Leriche syndrome and we needed 7 F access, 
a brachial artery was chosen. Because of the lack of an 
available proximal protection device, or any other solu-
tions to protect both branches of the venous graft during 
the angioplasty, we decided to use distal protection with 
a FilterWire to the branch supplying the larger myocardial 
area. The morphology of the bifurcated venous graft in 
our patient, especially the disproportion in the vessel 
lumen diameter, encouraged us to use a self-apposing 
sirolimus-eluting coronary stent (Stentys), as this device 
has been widely recommended in such complex condi-
tions. In bifurcation lesions, provisional stenting is the 
preferred technique.
Streszczenie
Pacjenta w wieku 71 lat po przebytej operacji pomostowania aortalno-wieńcowego przyjęto do Kliniki Kardiologii Inter-
wencyjnej Krakowskiego Szpitala Specjalistycznego im. Jana Pawła II z powodu ostrego zespołu wieńcowego — niestabil-
nej dławicy piersiowej. W angiografii wieńcowej wykazano obecność istotnego zwężenia rozwidlonego żylnego pomostu 
wieńcowego jako ostatniego funkcjonującego naczynia. Po kwalifikacji przez lokalny zespół sercowy u pacjenta wyko-
nano angioplastykę rozwidlonego pomostu żylnego z implantacją samorozprężalnego stentu uwalniającego sirolimus 
(Stentys). W opisie przypadku jest mowa o technicznych aspektach, takich jak wykorzystanie urządzeń do wspomagania 
funkcji lewej komory, dodatkowych metod obrazowania wieńcowego, rodzaju dostępu zabiegowego, rodzaju stentu 
i dystalnej protekcji naczynia. Pacjent z licznymi obciążeniami i istotnie obniżoną frakcją wyrzutową lewej komory jest 
raczej kandydatem do przezskórnej rewaskularyzacji niż do klasycznej operacji. Osiem miesięcy po zabiegu pacjentowi 
implantowano automatyczny kardiowerter-defibrylator w ramach prewencji pierwotnej nagłej śmierci sercowej w związ-
ku z objawową przewlekłą niewydolnością serca. W dyskusji omówiono problem długoterminowego efektu leczenia 
przezskórnego w tej grupie chorych. Rewaskularyzacja wieńcowa pacjenta z silnymi objawami ze zwężeniem ostatniego 
funkcjonującego naczynia wieńcowego powinna być obowiązkowa, choć liczne choroby współtowarzyszące zwiększają 
ryzyko zarówno operacji klasycznej, jak i przezskórnej angioplastyki. Zasadnicze pytanie brzmi: leczyć zabiegowo czy 
zachowawczo?
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